These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB. Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):321-4. PubMed ID: 2154418 [Abstract] [Full Text] [Related]
43. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme. Lipani JD, Jackson PS, Soltys SG, Sato K, Adler JR. Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497 [Abstract] [Full Text] [Related]
45. A phase I trial of surgery, Gliadel wafer implantation, and immediate postoperative carboplatin in combination with radiation therapy for primary anaplastic astrocytoma or glioblastoma multiforme. Limentani SA, Asher A, Heafner M, Kim JW, Fraser R. J Neurooncol; 2005 May 27; 72(3):241-4. PubMed ID: 15937647 [Abstract] [Full Text] [Related]
46. Concurrent modified PCV chemotherapy and radiotherapy in newly diagnosed grade IV astrocytoma. Murphy C, Pickles T, Knowling M, Thiesse B. J Neurooncol; 2002 May 27; 57(3):215-20. PubMed ID: 12125984 [Abstract] [Full Text] [Related]
47. Preradiation chemotherapy with VM-26 and CCNU in patients with glioblastoma multiforme. Mañé JM, Fernández R, Muñoz A, Rubio I, Ferreiro J, López-Argumedo G, Barceló R, López-Vivanco G. Tumori; 2004 May 27; 90(6):562-6. PubMed ID: 15762357 [Abstract] [Full Text] [Related]
48. A prospective study on glioblastoma in the elderly. Brandes AA, Vastola F, Basso U, Berti F, Pinna G, Rotilio A, Gardiman M, Scienza R, Monfardini S, Ermani M. Cancer; 2003 Feb 01; 97(3):657-62. PubMed ID: 12548608 [Abstract] [Full Text] [Related]
49. Combined treatment modality for anaplastic oligodendroglioma: a phase II study. Jeremic B, Shibamoto Y, Gruijicic D, Milicic B, Stojanovic M, Nikolic N, Dagovic A, Aleksandrovic J. J Neurooncol; 1999 Jun 01; 43(2):179-85. PubMed ID: 10533731 [Abstract] [Full Text] [Related]
51. Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: results of North Central Cancer Treatment Group protocol N0177. Krishnan S, Brown PD, Ballman KV, Fiveash JB, Uhm JH, Giannini C, Jaeckle KA, Geoffroy FJ, Nabors LB, Buckner JC, North Central Cancer Treatment Group. Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1192-9. PubMed ID: 16626884 [Abstract] [Full Text] [Related]
52. Prognostic factors in glioblastoma multiforme patients receiving high-dose particle radiotherapy or conventional radiotherapy. Matsuda M, Yamamoto T, Ishikawa E, Nakai K, Zaboronok A, Takano S, Matsumura A. Br J Radiol; 2011 Dec 15; 84 Spec No 1(Spec Iss 1):S54-60. PubMed ID: 21427185 [Abstract] [Full Text] [Related]
53. Carboplatin chemotherapy before irradiation in newly diagnosed glioblastoma multiforme. Gruber ML, Glass J, Choudhri H, Nirenberg A. Am J Clin Oncol; 1998 Aug 15; 21(4):338-40. PubMed ID: 9708629 [Abstract] [Full Text] [Related]
54. Survival results from a phase I study of etanidazole (SR2508) and radiotherapy in patients with malignant glioma. Chang EL, Loeffler JS, Riese NE, Wen PY, Alexander E, Black PM, Coleman CN. Int J Radiat Oncol Biol Phys; 1998 Jan 01; 40(1):65-70. PubMed ID: 9422559 [Abstract] [Full Text] [Related]
55. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Prados MD, Scott C, Sandler H, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ. Int J Radiat Oncol Biol Phys; 1999 Dec 01; 45(5):1109-15. PubMed ID: 10613302 [Abstract] [Full Text] [Related]
56. Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study. Jeremic B, Shibamoto Y, Grujicic D, Stojanovic M, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J. J Neurooncol; 2001 Jan 01; 51(2):133-41. PubMed ID: 11386410 [Abstract] [Full Text] [Related]
57. Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults. Matsutani M, Nakamura O, Nakamura M, Nagashima T, Asai A, Fujimaki T, Tanaka H, Ueki K, Tanaka Y. J Neurooncol; 1994 Jan 01; 19(3):227-37. PubMed ID: 7807173 [Abstract] [Full Text] [Related]
58. PCV chemotherapy for recurrent glioblastoma multiforme. Kappelle AC, Postma TJ, Taphoorn MJ, Groeneveld GJ, van den Bent MJ, van Groeningen CJ, Zonnenberg BA, Sneeuw KC, Heimans JJ. Neurology; 2001 Jan 09; 56(1):118-20. PubMed ID: 11148250 [Abstract] [Full Text] [Related]
59. Randomized trial of radiation therapy plus procarbazine, lomustine, and vincristine chemotherapy for supratentorial adult low-grade glioma: initial results of RTOG 9802. Shaw EG, Wang M, Coons SW, Brachman DG, Buckner JC, Stelzer KJ, Barger GR, Brown PD, Gilbert MR, Mehta MP. J Clin Oncol; 2012 Sep 01; 30(25):3065-70. PubMed ID: 22851558 [Abstract] [Full Text] [Related]
60. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C. J Clin Oncol; 1994 Oct 01; 12(10):2013-21. PubMed ID: 7931469 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]